Biologics and Biosimilars as Treatment Options for Psoriasis
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Yazar: | Moya, Amena Khatun |
---|---|
Diğer Yazarlar: | Kabir, Dr. Eva Rahman |
Materyal Türü: | Tez |
Dil: | en_US |
Baskı/Yayın Bilgisi: |
Brac University
2023
|
Konular: | |
Online Erişim: | http://hdl.handle.net/10361/17712 |
Benzer Materyaller
-
Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis
Yazar:: Akter, Anika
Baskı/Yayın Bilgisi: (2022) -
A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
Yazar:: Islam, Nahidul
Baskı/Yayın Bilgisi: (2023) -
Detection of skin diseases using deep learning
Yazar:: Shodoy, Masuk Ur Rahman
Baskı/Yayın Bilgisi: (2024) -
Biosimilar in lymphoma treatment
Yazar:: Tanisha, Mehrin Haque
Baskı/Yayın Bilgisi: (2021) -
Biosimilar insulins: a potential option in the treatment of Diabetes
Yazar:: Tabassum, Turana
Baskı/Yayın Bilgisi: (2022)